Literature DB >> 15960522

Convenient synthesis of N-methylamino acids compatible with Fmoc solid-phase peptide synthesis.

Eric Biron1, Horst Kessler.   

Abstract

N(alpha)-Methylamino acid containing peptides exhibit interesting therapeutic profiles and are increasingly recognized as potentially useful therapeutics. Unfortunately, their synthesis is hampered by the high price and unavaibility of many N(alpha)-methylamino acids. An efficient and practical preparation of N(alpha)-methyl-N(alpha)-(o-nitrobenzenesulfonyl)-alpha-amino acids without extensive purification is described. The procedure is based on the well-known N-alkylation of N(alpha)-arylsulfonylamino esters which was improved by using dimethyl sulfate and DBU as base. Ester cleavage is efficiently achieved by using an S(N)2-type saponification with lithium iodide, avoiding racemization observed with lithium hydroxide hydrolysis. Compatibility of the synthesized N(alpha)-methylamino acids with Fmoc solid-phase peptide synthesis is demonstrated by using normal coupling conditions to efficiently prepare N-methyl dipeptides. The described procedure allows the preparation of N(alpha)-methylamino acids in a very short period of time and a rapid synthesis of N-methyl peptides using Fmoc solid-phase peptide synthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15960522     DOI: 10.1021/jo050477z

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  12 in total

Review 1.  Peptidomimetics, a synthetic tool of drug discovery.

Authors:  Josef Vagner; Hongchang Qu; Victor J Hruby
Journal:  Curr Opin Chem Biol       Date:  2008-05-14       Impact factor: 8.822

2.  Engineering strategy to improve peptide analogs: from structure-based computational design to tumor homing.

Authors:  David Zanuy; Francisco J Sayago; Guillem Revilla-López; Gema Ballano; Lilach Agemy; Venkata Ramana Kotamraju; Ana I Jiménez; Carlos Cativiela; Ruth Nussinov; April M Sawvel; Galen Stucky; Erkki Ruoslahti; Carlos Alemán
Journal:  J Comput Aided Mol Des       Date:  2012-12-14       Impact factor: 3.686

Review 3.  Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge.

Authors:  Victor J Hruby; Minying Cai; James Cain; Joel Nyberg; Dev Trivedi
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

4.  Synthesis of a large library of macrocyclic peptides containing multiple and diverse N-alkylated residues.

Authors:  Jumpei Morimoto; Thomas Kodadek
Journal:  Mol Biosyst       Date:  2015-10

5.  Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies.

Authors:  Lucas Doedens; Florian Opperer; Minying Cai; Johannes G Beck; Matt Dedek; Erin Palmer; Victor J Hruby; Horst Kessler
Journal:  J Am Chem Soc       Date:  2010-06-16       Impact factor: 15.419

6.  Synthesis and screening of stereochemically diverse combinatorial libraries of peptide tertiary amides.

Authors:  Yu Gao; Thomas Kodadek
Journal:  Chem Biol       Date:  2013-03-21

7.  N-Methyl scanning mutagenesis generates protease-resistant G protein ligands with improved affinity and selectivity.

Authors:  Stephen V Fiacco; Richard W Roberts
Journal:  Chembiochem       Date:  2008-09-22       Impact factor: 3.164

8.  Homotyrosine-containing cyanopeptolins 880 and 960 and anabaenopeptins 908 and 915 from Planktothrix agardhii CYA 126/8.

Authors:  Hilary S Okumura; Benjamin Philmus; Cyril Portmann; Thomas K Hemscheidt
Journal:  J Nat Prod       Date:  2009-01       Impact factor: 4.050

9.  Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides.

Authors:  Yaniv Linde; Oded Ovadia; Eli Safrai; Zhimin Xiang; Federico P Portillo; Deborah E Shalev; Carrie Haskell-Luevano; Amnon Hoffman; Chaim Gilon
Journal:  Biopolymers       Date:  2008       Impact factor: 2.505

Review 10.  Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints.

Authors:  Jonathan E Bock; Jason Gavenonis; Joshua A Kritzer
Journal:  ACS Chem Biol       Date:  2012-11-30       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.